<DOC>
	<DOCNO>NCT00348686</DOCNO>
	<brief_summary>The purpose study investigate effect candesartan base therapy percent change B type natriuretic peptide ( BNP ) level subject hypertension leave ventricular hypertrophy .</brief_summary>
	<brief_title>Candesartan Effectiveness Study Pro-B Type Natriuretic Peptides ( BNP )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Hypertension diastolic blood pressure within 95115 mm/Hg or/and systolic blood pressure within 160200 mm/Hg Patients diagnose left ventricular hypertrophy electrocardiogram Secondary hypertension History myocardial infarction Stroke within previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>LVH</keyword>
</DOC>